Ana C. Parente‐Pereira

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

Lynsey M. Whilding, Leena Halim, Benjamin Draper et al. · Cancers · 2019 · 202 citations · Full text

Life Sciences, Immunology, Oncology +17

Ovarian Cancer Immunotherapy Using PD‐L1 siRNA Targeted Delivery from Folic Acid‐Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing

Pei Y. Teo, Chuan Yang, Lynsey M. Whilding et al. · Advanced Healthcare Materials · 2015 · 172 citations

Pharmacy, Oncology, Pharmaceutics +17

Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?

Sjoukje J. C. van der Stegen, David M. Davies, Scott Wilkie et al. · The Journal of Immunology · 2013 · 128 citations

Life Sciences, Immunology, Oncology +17

In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate

Francis Man, Lindsay Lim, Alessia Volpe et al. · Molecular Therapy · 2018 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17

Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice

Ana C. Parente‐Pereira, Jerome Burnet, David H. Ellison et al. · Journal of Clinical Immunology · 2011 · 115 citations

Life Sciences, Cell Biology, Immunology +14